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Introduction: Constrictive pericarditis is characterized by constriction of the heart secondary to pericardial inflammation. Cardiovascular 
magnetic resonance (CMR) imaging is useful imaging modality for addressing the challenges of confirming this diagnosis. It can be 
used to exclude other causes of right heart failure, such as pulmonary hypertension or myocardial infarction, determine whether the 
pericardium is causing constriction and differentiate it from restrictive cardiomyopathy, which also causes impaired cardiac filling.
Case Presentation: A 77-year-old man from a country with high incidence of tuberculosis presented with severe dyspnea. 
Echocardiography revealed a small left ventricle with normal systolic and mildly impaired diastolic function. Left heart catheterization 
revealed non-obstructive coronary disease, not felt contributory to the dyspnea. Anatomy imaging with cardiovascular magnetic 
resonance imaging (CMR) showed global, severely thickened pericardium. Short tau inversion recovery (STIR) sequences for detection 
of oedema/ inflammation showed increased signal intensity and free breathing sequences confirmed septal flattening on inspiration. 
Late gadolinium imaging confirmed enhancement in the pericardium, with all findings suggestive of pericardial inflammation and 
constriction.
Conclusions: CMR with STIR sequences, free breathing sequences and late gadolinium imaging can prove extremely useful for diagnosing 
constrictive pericarditis.
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1. Introduction
Constrictive pericarditis was first described by Lower in 
1669 (1) and is characterized by constriction of the heart 
secondary to pericardial inflammation. Common causes 
include repeated pericarditis, previous cardiac surgery 
and radiation therapy. However, less commonly, it can be 
caused by tuberculosis particularly in sub-Saharan Africa 
and parts of Asia (2), neoplasms, autoimmune disorders or 
uraemia. Here, we report a rare cause of constrictive peri-
carditis of tuberculous etiology in an immunocompetent 
patient, where the diagnosis was reached with the help of 
cardiovascular magnetic resonance imaging (CMR).
2. Case Presentation
A 77-year-old man originating from a country with high 
incidence of tuberculosis, presented with severe increasing 
dyspnea to our institution. Echocardiography revealed a 
small left ventricle (LV) with normal systolic but mildly im-
paired diastolic function. Trans-mitral and trans-tricuspid 
Doppler demonstrated variations in LV and right ventricu-
lar (RV) filling, respectively, of 30%. The peak E and A veloci-
ties were 43.8 and 51.5 cm/s, respectively, resulting in an E/A 
ratio of 0.9. Tissue Doppler measurements demonstrated E’ 
septal velocity of 6.0 cm/s and E’ lateral velocity of 7.7 cm/s. 
These findings were suggestive of pericardial constriction 
with a restrictive component, however it had not been pos-
sible to identify the aetiology. Left heart catheterization 
revealed non-obstructive coronary artery disease, which 
was not felt significant to explain the degree of breathless-
ness. Cardiovascular magnetic resonance imaging (CMR) 
was performed three days later and showed a small LV with 
mildly impaired ejection fraction and normal indexed 
mass. This study also demonstrated global, severely thick-
ened pericardium (maximum thickness of 13 mm, normal 
< 3 mm), comprising of both pericardial thickening and a 
small effusive component along the lateral aspect of the 
LV and large bilateral pleural effusions (Figure 1A). Short 
tau inversion recovery (STIR) sequences showed increased 
signal intensity and imaging in the late phase after admin-
istration of the paramagnetic contrast agent gadolinium 
confirmed enhancement in the pericardium (Figure 1B 
and C), both suggesting pericardial inflammation. Further-
more, there was marked septal flattening on inspiration 
and ventricular septal bounce consistent with constrictive 
physiology (Supplementary Video 1). These findings strong-
ly supported the diagnosis of constrictive pericarditis most 
likely of a tuberculous etiology. The patient passed away 
shortly after the CMR and histology demonstrated fibrotic 
pericardium, accompanied by chronic inflammation with 
numerous epitheloid granulomas and marked central ca-
seous necrosis, confirming mycobacterial infection.
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Figure 1. Cardiovascular Magnetic Resonance Imaging
A, Demonstrating significant bilateral pleural effusion and pericardial thickening (13 mm). B, Short tau inversion recovery sequences (fat suppression) 
showing increased pericardial edema, suggestive of inflammation. C, Delayed gadolinium enhancement was observed ion the pericardium, in keeping 
with pericardial inflammation. These images are consistent with constrictive pericarditis with a tuberculous origin later confirmed by histology.
Video 1: To see the video, refer to article’s online version.
3. Discussion
Constrictive pericarditis is characterized by constric-
tion of the heart secondary to pericardial inflammation. 
Common causes include repeated pericarditis, previous 
cardiac surgery and radiation therapy (3). Less common-
ly it can be caused by tuberculosis (TB) particularly in 
sub-Saharan Africa and parts of Asia (2) and patients with 
tuberculous pericarditis often have concomitant human 
immunodeficiency virus (HIV) infection (4). Our patient 
did not have HIV, but it is interesting to note that HIV 
can alter the natural history, progression and outcomes 
of tuberculous pericarditis. Immunocompromised pa-
tients appear less likely to develop constrictive pericardi-
tis but nonetheless have a significantly higher mortality 
compared with their immunocompetent counterparts 
(5). Tuberculous pericarditis represents a form of extra-
pulmonary tuberculosis and remains unusual in the 
Western world. Other causes of constrictive pericarditis 
include neoplasms, autoimmune disorders and uraemia. 
Constriction causes impaired diastolic filling, in turn 
producing three important effects (3).
First, there is dissociation between intra-thoracic and 
intra-cardiac pressures. The pressure gradient between 
the pulmonary veins and the left atrium is decreased, 
impairing left sided diastolic filling and trans-mitral 
flow. Secondly, there is increased inter-ventricular depen-
dence; during inspiration, decreased left ventricular fill-
ing induces increased right ventricular filling, causing a 
right-to-left septal shift, and increases in the tricuspid in-
flow E velocity and hepatic vein diastolic forward velocity. 
The opposite occurs with expiration. Finally, increased 
cardiac filling pressures with pressure equalization in all 
four cardiac chambers occur.
These functional consequences can be assessed by mul-
tiple modalities (6):
Echocardiography may show a restrictive physiology 
pattern, including an increased early (E) to late (A) ra-
tio of mitral filling velocities of greater than 0.8 with a 
preserved or raised diastolic mitral annular relaxation 
velocity (e’), plethoric inferior vena cava and flat Doppler 
profile in the superior vena cava (6). In contrast, cardiac 
catheterization with hemodynamic pressure waveform 
monitoring may reveal respiratory discordance of simul-
taneous left and right ventricular systolic pressures. This 
is reflected by an increase in systolic area index, which is 
defined as the ratio of right ventricular to left ventricular 
systolic area in inspiration versus expiration (7). More-
over, cardiac computed tomography can show a thick-
ened and calcified pericardium as well as dilated supra-
hepatic inferior vena cava both supporting constriction. 
It can also be used to exclude other causes of hyperten-
sion and right heart failure and in particular acute or 
chronic pulmonary thrombo-embolism as well as poten-
tial neoplastic lesions responsible for the constriction.
Finally, CMR imaging is useful for addressing the chal-
lenges of confirming a diagnosis of constrictive pericar-
ditis by both visualizing the thickened pericardium and 
also allowing via free breathing sequences to look for 
ventricular septal flattening on inspiration suggesting 
constrictive physiology (8). CMR can also detect rare com-
plications of tuberculous pericarditis such as left ventric-
ular pseudo-aneurysms (9). CMR can additionally be used 
to exclude other causes of right heart failure, such as pul-
monary hypertension or myocardial infarction. It can de-
termine whether the pericardium is causing constriction 
and may differentiate it from restrictive cardiomyopathy, 
which also causes impaired cardiac filling (10). This dis-
tinction is crucial as constrictive pericarditis can be suc-
cessfully treated by early pericardiectomy (11) (with medi-
cal therapy showing no benefit over placebo (2)), whereas 
the optimal treatment for restrictive cardiomyopathy is 
medical therapy (12).
Findings favouring the diagnosis of constrictive peri-
carditis include increased pericardial thickening, oe-
dema, active inflammation and fibrosis. Nevertheless, 
pericardial thickening per se does not necessarily imply 
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pericardial constriction (13) and constrictive pericarditis 
can occur despite normal pericardial thickness (14). Dur-
ing CMR, STIR sequences allowed detection of pericar-
dial inflammation, as did late gadolinium enhancement 
(LGE). The latter has been previously described in tuber-
culous constrictive pericarditis (15) and subsequently 
associated with fibroblastic proliferation, chronic in-
flammation and neovascularization (16). The presence 
of inflammation is clinically important because such pa-
tients may benefit from non-steroidal anti-inflammatory 
drug (NSAID) therapy and the constrictive pericarditis 
observed may be reversible (16).
A restrictive physiology of increased early diastolic fill-
ing and absent late filling can be demonstrated using 
velocity-coded phase contrast CMR; septal bounce due 
to respiration-related variations in cardiac filling can be 
observed in bright blood cine images, whereas ventricu-
lar inter-dependence can be evaluated using real-time 
cine sequences (17). The nature of any pericardial fluid 
present can also be determined using CMR; a transudate 
shows low signal intensity during T1-weighted spin-echo 
sequences but high signal intensity in T2-weighted se-
quences. In contrast, an exudate shows high intensity 
during T1 but low intensity during T2 sequences. Adher-
ence of the pericardium to the underlying myocardium 
can be confirmed by tagging (18).
Despite a significant decline in the TB seen in wealth-
ier industrialized countries in the last century, the esti-
mated number of new TB cases has increased steadily to 
over 10 million in 2005 (19). Tuberculous pericarditis is 
caused by Mycobacterium tuberculosis and can be found 
in up to 1% of the autopsied cases of patients with TB, 
and up to 2% of the cases of pulmonary TB. Without treat-
ment mortality exceeds 90% whereas anti-tuberculous 
therapy, usually in the form of rifampicin, isoniazid, 
pyrazinamide, and ethambutol for at least two months, 
followed by isoniazid and rifampicin for another four 
months, is highly effective in treating patients with 
extra-pulmonary TB and can reduce the mortality to un-
der 20% in immunocompetent individuals and ~30% in 
HIV-infected patients. Reaching the correct diagnosis is 
therefore crucial in initiating appropriate therapy. Con-
strictive pericarditis is the most serious sequel of tuber-
culous pericarditis and management involves prompt 
initiation of anti-tuberculous therapy and appropriate 
timing of pericardiectomy for selected patients who 
have failed to respond to medical therapy (19).
In summary, diagnostic evaluation of constrictive peri-
carditis is important and can direct correct manage-
ment. Appropriate evaluation requires a multi-modality 
approach and suspected patients would benefit from 
simple tests such as echocardiography but also further, 
more complex imaging, including CT and CMR. CMR 
can be particularly useful as it can demonstrates cardiac 
morphology and structures to a high resolution. It fur-
ther enables the detection of pericardial thickening and 
inflammation, adhesion of the pericardium to the myo-
cardium, ventricular coupling and cardiac filling as well 
as characterisation of any pericardial fluid. We therefore 
recommend that CMR should be considered early, if re-
sources allow, for all patients with strong suspicion of 
constrictive pericarditis, as it can confirm its diagnosis, 
help identify the aetiology and guide appropriate man-
agement.
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